BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 12418444)

  • 1. Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis.
    Frankel SK; Sullivan EJ; Brown KK
    Crit Care Clin; 2002 Oct; 18(4):855-79. PubMed ID: 12418444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.
    Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S
    Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulomatous Vasculitis.
    Sharma A; Dogra S; Sharma K
    Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Guidelines in Vasculitis.
    Kermani TA; Warrington KJ; Dua AB
    Rheum Dis Clin North Am; 2022 Aug; 48(3):705-724. PubMed ID: 35953232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABC of arterial and vascular disease: vasculitis.
    Savage CO; Harper L; Cockwell P; Adu D; Howie AJ
    BMJ; 2000 May; 320(7245):1325-8. PubMed ID: 10807632
    [No Abstract]   [Full Text] [Related]  

  • 6. Do vasculitis categorization systems really matter?
    Jennette JC; Falk RJ
    Curr Rheumatol Rep; 2000 Oct; 2(5):430-8. PubMed ID: 11123094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature.
    Sørensen SF; Slot O; Tvede N; Petersen J
    Ann Rheum Dis; 2000 Jun; 59(6):478-82. PubMed ID: 10834866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasculitis. A collection of pearls and myths.
    Stone JH; Calabrese LH; Hoffman GS; Pusey CD; Hunder GG; Hellmann DB
    Rheum Dis Clin North Am; 2001 Nov; 27(4):677-728, v. PubMed ID: 11723760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update of neurological manifestations of vasculitides and connective tissue diseases: a literature review.
    Bougea A; Anagnostou E; Spandideas N; Triantafyllou N; Kararizou E
    Einstein (Sao Paulo); 2015; 13(4):627-35. PubMed ID: 26313435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment.
    Guillevin L; Lhote F; Gherardi R
    Neurol Clin; 1997 Nov; 15(4):865-86. PubMed ID: 9367969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous vasculitis in Latin America.
    Ramos-e-Silva M; Carneiro SC
    Clin Dermatol; 1999; 17(6):663-70. PubMed ID: 10631528
    [No Abstract]   [Full Text] [Related]  

  • 12. Polyarteritis Nodosa and Eosinophilic Granulomatosis With Polyangiitis Presenting as Distal Extremity Muscular Edema and Pain.
    Kim JW; Mills B; Rashid H; Solow EB
    J Clin Rheumatol; 2021 Dec; 27(8S):S775-S776. PubMed ID: 32658049
    [No Abstract]   [Full Text] [Related]  

  • 13. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment.
    Lhote F; Guillevin L
    Rheum Dis Clin North Am; 1995 Nov; 21(4):911-47. PubMed ID: 8592743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
    Guillevin L
    Presse Med; 2007 May; 36(5 Pt 2):843-4. PubMed ID: 17449373
    [No Abstract]   [Full Text] [Related]  

  • 15. [Granulomatous vasculitides and vasculitides with extravascular granulomatosis].
    Arnold S; Klapa S; Holl-Ulrich K; Müller A; Kerstein-Stähle A; Lamprecht P
    Z Rheumatol; 2022 Sep; 81(7):558-566. PubMed ID: 35962194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Classification of systemic vasculitides].
    Guillevin L; Pagnoux C
    Rev Prat; 2008 Mar; 58(5):480-6. PubMed ID: 18524103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update in the diagnosis and management of pulmonary vasculitis.
    Frankel SK; Cosgrove GP; Fischer A; Meehan RT; Brown KK
    Chest; 2006 Feb; 129(2):452-465. PubMed ID: 16478866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When should immunosuppressants be prescribed to treat systemic vasculitides?
    Guillevin L; Pagnoux C
    Intern Med; 2003 Apr; 42(4):313-7. PubMed ID: 12729318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasculitis: a collection of pearls and myths.
    Stone JH
    Rheum Dis Clin North Am; 2007 Nov; 33(4):691-739, v. PubMed ID: 18037113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurologic manifestations of systemic vasculitides.
    Moore PM; Calabrese LH
    Semin Neurol; 1994 Dec; 14(4):300-6. PubMed ID: 7709080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.